supernus pharmaceuticals inc
(SUPN:Consolidated Issue listed on NASDAQ Global Market)
William A. Nuerge
Director, Member of Compensation Committee and Member of Audit Committee, Supernus Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Mr. William A. Nuerge, also known as Bill, serves as a Managing Partner of Fortress Pharms Advisors, LLC. Mr. Nuerge served as the Chief Executive Officer of Xanodyne Pharmaceuticals, Inc., from November, 2004 to April 2007 and also served as its Consultant from March 2004 to November 2004. He has 30 years pharmaceutical industry experience and is noted for his high quality project management skills and his ability to identify talent, to motivate and to lead. He began ...
1550 East Gude DrivePhone: 301-838-2500
Rockville, Maryland 20850
Board Members Memberships*
Former Chief Executive Officer and Director
Director, Member of Compensation Committee and Member of Audit Committee
Indiana Wesleyan University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|James E. Brown D.V.M.||Co-Founder, Chief Executive Officer, President and Director|
|James A. Schoeneck||Chief Executive Officer, President and Director|
|William J. Polvino M.D.||Chief Executive Officer and President|
Veloxis Pharmaceuticals A/S
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|€1.9M||Compensation as of Fiscal Year 2014.|